Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Capital Expenditures (2021 - 2025)

Healthcare Triangle filings provide 4 years of Capital Expenditures readings, the most recent being $3000.0 for Q3 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to $3000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $13000.0, a N/A change, with the full-year FY2025 number at $6000.0, changed N/A from a year prior.
  • Capital Expenditures reached $3000.0 in Q3 2025 per HCTI's latest filing, down from $5000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $29000.0 in Q4 2021, with the low at -$2000.0 in Q2 2023.
  • A 4-year average of $8545.5 and a median of $5000.0 in 2023 define the central range for Capital Expenditures.
  • Peak annual rise in Capital Expenditures hit 25.0% in 2023, while the deepest fall reached 200.0% in 2023.
  • Year by year, Capital Expenditures stood at $29000.0 in 2021, then tumbled by 51.72% to $14000.0 in 2022, then tumbled by 64.29% to $5000.0 in 2023, then plummeted by 40.0% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Capital Expenditures are $3000.0 (Q3 2025), $5000.0 (Q4 2023), and $5000.0 (Q3 2023).